INTEGRA LIFESCIENCES HOLDINGS CORP Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net of $378.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Income Statement › Other Income
us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet · last filed 2026-07-29
- INTEGRA LIFESCIENCES HOLDINGS CORP derivative instruments not designated as hedging instruments, gain (loss), net for the quarter ending 2026-06-30 was $378.00K.
- INTEGRA LIFESCIENCES HOLDINGS CORP derivative instruments not designated as hedging instruments, gain (loss), net for the quarter ending 2026-03-31 was -$276.00K, a 180.47% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP derivative instruments not designated as hedging instruments, gain (loss), net for the quarter ending 2025-12-31 was -$71.00K, a 126.39% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP derivative instruments not designated as hedging instruments, gain (loss), net for the quarter ending 2025-09-30 was -$227.00K, a 2370.00% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP derivative instruments not designated as hedging instruments, gain (loss), net for fiscal 2025 was -$1.98M, a 401.99% decline from fiscal 2024.
- INTEGRA LIFESCIENCES HOLDINGS CORP derivative instruments not designated as hedging instruments, gain (loss), net for fiscal 2024 was $654.00K, a 15.55% increase from fiscal 2023.
- INTEGRA LIFESCIENCES HOLDINGS CORP derivative instruments not designated as hedging instruments, gain (loss), net for fiscal 2023 was $566.00K, a 55.01% decline from fiscal 2022.
- INTEGRA LIFESCIENCES HOLDINGS CORP derivative instruments not designated as hedging instruments, gain (loss), net for fiscal 2022 was $1.26M, a 176.48% increase from fiscal 2021.
| Period end | Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net 3 month | Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net 3 month as first filed | Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net 6 month | Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net 9 month | Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net 9 month as first filed | Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $378.00K 10-Q · filed 2026-07-29 | $102.00K 10-Q · filed 2026-07-29 | $31.00K derived: sum of 3 quarters · filed 2026-07-29 | -$196.00K derived: sum of 4 quarters · filed 2026-07-29 | ||
| 2026-03-31 | -$276.00K 10-Q · filed 2026-05-05 | -$347.00K derived: sum of 2 quarters · filed 2026-05-05 | -$574.00K derived: sum of 3 quarters · filed 2026-05-05 | -$2.59M derived: sum of 4 quarters · filed 2026-07-29 | ||
| 2025-12-31 | -$71.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$298.00K derived: sum of 2 quarters · filed 2026-02-26 | -$2.32M derived: sum of 3 quarters · filed 2026-07-29 | -$1.98M 10-K · filed 2026-02-26 | ||
| 2025-09-30 | -$227.00K 10-Q · filed 2025-10-30 | -$2.25M derived: sum of 2 quarters · filed 2026-07-29 | -$1.90M 10-Q · filed 2025-10-30 | -$1.64M derived: sum of 4 quarters · filed 2026-07-29 | ||
| 2025-06-30 | -$2.02M 10-Q · filed 2026-07-29 | -$1.68M 10-Q · filed 2026-07-29 | -$1.41M derived: sum of 3 quarters · filed 2026-07-29 | -$1.40M derived: sum of 4 quarters · filed 2026-07-29 | ||
| 2025-03-31 | $343.00K 10-Q · filed 2026-05-05 | $612.00K derived: sum of 2 quarters · filed 2026-05-05 | $622.00K derived: sum of 3 quarters · filed 2026-05-05 | $757.00K derived: sum of 4 quarters · filed 2026-05-05 | ||
| 2024-12-31 | $269.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $279.00K derived: sum of 2 quarters · filed 2026-02-26 | $414.00K derived: sum of 3 quarters · filed 2026-02-26 | $654.00K 10-K · filed 2026-02-26 | ||
| 2024-09-30 | $10.00K 10-Q · filed 2025-10-30 | $145.00K derived: sum of 2 quarters · filed 2025-10-30 | $385.00K 10-Q · filed 2025-10-30 | $206.00K derived: sum of 4 quarters · filed 2025-10-30 | ||
| 2024-06-30 | $135.00K 10-Q · filed 2025-07-31 | $408.00K 10-Q · filed 2025-07-31 | $196.00K derived: sum of 3 quarters · filed 2025-07-31 | $331.00K derived: sum of 4 quarters · filed 2025-07-31 | ||
| 2024-03-31 | $273.00K 10-Q · filed 2025-05-05 | $61.00K derived: sum of 2 quarters · filed 2025-05-05 | $196.00K derived: sum of 3 quarters · filed 2025-05-05 | $784.00K derived: sum of 4 quarters · filed 2025-05-05 | ||
| 2023-12-31 | -$212.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | -$77.00K derived: sum of 2 quarters · filed 2025-02-25 | $511.00K derived: sum of 3 quarters · filed 2025-02-25 | $566.00K 10-K · filed 2025-02-25 | ||
| 2023-09-30 | $135.00K 10-Q · filed 2024-11-04 | $723.00K derived: sum of 2 quarters · filed 2024-11-04 | $778.00K 10-Q · filed 2024-11-04 | $888.00K derived: sum of 4 quarters · filed 2024-11-04 | ||
| 2023-06-30 | $588.00K 10-Q · filed 2024-07-29 | $643.00K 10-Q · filed 2024-07-29 | $753.00K derived: sum of 3 quarters · filed 2024-07-29 | $1.08M derived: sum of 4 quarters · filed 2024-07-29 | ||
| 2023-03-31 | $55.00K 10-Q · filed 2024-05-06 | $165.00K derived: sum of 2 quarters · filed 2024-05-06 | $493.00K derived: sum of 3 quarters · filed 2024-05-06 | $953.00K derived: sum of 4 quarters · filed 2024-05-06 | ||
| 2022-12-31 | $110.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $438.00K derived: sum of 2 quarters · filed 2024-02-28 | $898.00K derived: sum of 3 quarters · filed 2024-02-28 | $1.26M 10-K · filed 2024-02-28 | ||
| 2022-09-30 | $328.00K 10-Q · filed 2023-10-25 | $1.35M 10-Q · filed 2022-10-26 | $788.00K derived: sum of 2 quarters · filed 2023-10-25 | $1.15M 10-Q · filed 2023-10-25 | $2.93M 10-Q · filed 2022-10-26 | $1.39M derived: sum of 4 quarters · filed 2023-10-25 |
| 2022-06-30 | $460.00K 10-Q · filed 2023-07-27 | $820.00K 10-Q · filed 2023-07-27 | $1.06M derived: sum of 3 quarters · filed 2023-07-27 | $1.17M derived: sum of 4 quarters · filed 2023-07-27 | ||
| 2022-03-31 | $360.00K 10-Q · filed 2023-04-26 | $597.00K derived: sum of 2 quarters · filed 2023-04-26 | $707.00K derived: sum of 3 quarters · filed 2023-04-26 | |||
| 2021-12-31 | $237.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $347.00K derived: sum of 2 quarters · filed 2023-02-22 | $455.00K 10-K · filed 2023-02-22 | |||
| 2021-09-30 | $110.00K 10-Q · filed 2022-10-26 | $218.00K 10-Q · filed 2022-10-26 | ||||
| 2012-03-31 | -$100.00K 10-Q · filed 2012-04-26 | |||||
| 2011-12-31 | $300.00K 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |